Raras
Buscar doenças, sintomas, genes...
Síndrome Brugada
ORPHA:130CID-10 · I49.8CID-11 · BC65.1DOENÇA RARA

Uma doença com causas genéticas variadas, caracterizada por um bloqueio (total ou parcial) na "fiação elétrica" do lado direito do coração, e uma alteração no exame de eletrocardiograma (ECG), que mostra uma "elevação de ST" em pontos específicos (V1-V3). É comum que pessoas com essa condição tenham arritmias (batimentos cardíacos irregulares), originadas nos ventrículos (câmaras inferiores do coração), o que pode levar à morte súbita.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença com causas genéticas variadas, caracterizada por um bloqueio (total ou parcial) na "fiação elétrica" do lado direito do coração, e uma alteração no exame de eletrocardiograma (ECG), que mostra uma "elevação de ST" em pontos específicos (V1-V3). É comum que pessoas com essa condição tenham arritmias (batimentos cardíacos irregulares), originadas nos ventrículos (câmaras inferiores do coração), o que pode levar à morte súbita.

Pesquisas ativas
13 ensaios
54 total registrados no ClinicalTrials.gov
Publicações científicas
4.436 artigos
Último publicado: 2026 Apr 7

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
20.0
Europe
Início
Adult
+ childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: I49.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

55%prev.
Síncope
Frequente (79-30%)
55%prev.
Parada cardíaca
Frequente (79-30%)
55%prev.
Elevação do segmento ST
Frequente (79-30%)
55%prev.
Bloqueio do ramo direito
Frequente (79-30%)
17%prev.
Bloqueio atrioventricular de primeiro grau
Ocasional (29-5%)
17%prev.
Taquicardia
Ocasional (29-5%)
27sintomas
Frequente (4)
Ocasional (6)
Muito raro (2)
Sem dados (15)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 27 características clínicas mais associadas, ordenadas por frequência.

SíncopeSyncope
Frequente (79-30%)55%
Parada cardíacaCardiac arrest
Frequente (79-30%)55%
Elevação do segmento STST segment elevation
Frequente (79-30%)55%
Bloqueio do ramo direitoRight bundle branch block
Frequente (79-30%)55%
Bloqueio atrioventricular de primeiro grauFirst degree atrioventricular block
Ocasional (29-5%)17%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico4.436PubMed
Últimos 10 anos200publicações
Pico2025143 papers
Linha do tempo
2026Hoje · 2026🧪 1992Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

22 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

SCN3BSodium channel regulatory subunit beta-3Candidate gene tested inModerado
FUNÇÃO

Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Brugada syndrome 7

A tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
68.3 TPM
Córtex cerebral
56.1 TPM
Pituitária
51.6 TPM
Brain Anterior cingulate cortex BA24
42.6 TPM
Hipocampo
34.5 TPM
OUTRAS DOENÇAS (3)
Brugada syndrome 7Brugada syndromefamilial atrial fibrillation
HGNC:20665UniProt:Q9NY72
ABCC9ATP-binding cassette sub-family C member 9Candidate gene tested inRestrito
FUNÇÃO

Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation (PubMed:9831708). Can form a sulfonylurea-sensitive but ATP-insensitive potassium channel with KCNJ8 (By similarity)

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (3)
Ion homeostasisABC-family proteins mediated transportATP sensitive Potassium channels
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1O

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

OUTRAS DOENÇAS (7)
hypertrichotic osteochondrodysplasia Cantu typeintellectual disability and myopathy syndromeatrial fibrillation, familial, 12dilated cardiomyopathy 1O
HGNC:60UniProt:O60706
SEMA3ASemaphorin-3ADisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Involved in the development of the olfactory system and in neuronal control of puberty. Induces the collapse and paralysis of neuronal growth cones. Could serve as a ligand that guides specific growth cones by a motility-inhibiting mechanism. Binds to the complex neuropilin-1/plexin-1

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (3)
Sema3A PAK dependent Axon repulsionSEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesionCRMPs in Sema3A signaling
MECANISMO DE DOENÇA

Hypogonadotropic hypogonadism 16 with or without anosmia

A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH).

EXPRESSÃO TECIDUAL(Tecido-específico)
Cólon sigmoide
14.5 TPM
Esôfago - Muscular
13.6 TPM
Esôfago - Junção
13.2 TPM
Bladder
7.0 TPM
Cólon transverso
4.9 TPM
OUTRAS DOENÇAS (3)
Kallmann syndromeBrugada syndromehypogonadotropic hypogonadism 16 with or without anosmia
HGNC:10723UniProt:Q14563
KCNJ8ATP-sensitive inward rectifier potassium channel 8Candidate gene tested inTolerante
FUNÇÃO

Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:20558321, PubMed:21836131, PubMed:24700710, PubMed:28842488). The inward rectification is

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (1)
ATP sensitive Potassium channels
EXPRESSÃO TECIDUAL(Ubíquo)
Tecido adiposo
43.8 TPM
Adipose Visceral Omentum
40.8 TPM
Útero
40.3 TPM
Coração - Ventrículo esquerdo
40.2 TPM
Esôfago - Junção
39.0 TPM
OUTRAS DOENÇAS (2)
Brugada syndromehypertrichotic osteochondrodysplasia Cantu type
HGNC:6269UniProt:Q15842
SCN10ASodium channel protein type 10 subunit alphaCandidate gene tested inTolerante
FUNÇÃO

Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Episodic pain syndrome, familial, 2

An autosomal dominant neurologic disorder characterized by adult-onset of paroxysmal pain mainly affecting the distal lower extremities.

EXPRESSÃO TECIDUAL(Não detectado)
Testículo
0.5 TPM
Coração - Átrio
0.1 TPM
Aorta
0.1 TPM
Coração - Ventrículo esquerdo
0.0 TPM
Artéria coronária
0.0 TPM
OUTRAS DOENÇAS (7)
episodic pain syndrome, familial, 2paroxysmal extreme pain disorderfamilial long QT syndromeBrugada syndrome
HGNC:10582UniProt:Q9Y5Y9
KCNE3Potassium voltage-gated channel subfamily E member 3Candidate gene tested inModerado
FUNÇÃO

Ancillary protein that functions as a regulatory subunit of the voltage-gated potassium (Kv) channel complex composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits. KCNE3 beta subunit modulates the gating kinetics and enhances stability of the channel complex (PubMed:10646604, PubMed:11207363, PubMed:12954870). Alters the gating of the delayed rectifier Kv channel containing KCNB1 alpha subunit (PubMed:12954870). Associates with KCNC4/Kv3.4 alpha subunit

LOCALIZAÇÃO

Cell membraneCytoplasmPerikaryonCell projection, dendriteMembrane raft

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Brugada syndrome 6

A tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset.

EXPRESSÃO TECIDUAL(Ubíquo)
Sangue
18.2 TPM
Intestino delgado
12.5 TPM
Baço
11.1 TPM
Ovário
10.2 TPM
Glândula salivar
10.1 TPM
OUTRAS DOENÇAS (3)
Brugada syndrome 6Brugada syndromehypokalemic periodic paralysis
HGNC:6243UniProt:Q9Y6H6
CACNA2D1Voltage-dependent calcium channel subunit alpha-2/delta-1Candidate gene tested inAltamente restrito
FUNÇÃO

The alpha-2/delta subunit of voltage-dependent calcium channels regulates calcium current density and activation/inactivation kinetics of the calcium channel (PubMed:35293990). Plays an important role in excitation-contraction coupling (By similarity)

LOCALIZAÇÃO

MembraneCell membrane

VIAS BIOLÓGICAS (1)
Presynaptic depolarization and calcium channel opening
MECANISMO DE DOENÇA

Developmental and epileptic encephalopathy 110

A form of epileptic encephalopathy, a heterogeneous group of early-onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. DEE110 is an autosomal recessive form characterized by profound global developmental delay and hypotonia apparent in infancy followed by onset of seizures in the first months or years of life.

OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy 110undetermined early-onset epileptic encephalopathyBrugada syndromeshort QT syndrome
HGNC:1399UniProt:P54289
KCND3A-type voltage-gated potassium channel KCND3Candidate gene tested inAltamente restrito
FUNÇÃO

Pore-forming (alpha) subunit of voltage-gated A-type potassium channels that mediates transmembrane potassium transport in excitable membranes, in brain and heart (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). In cardiomyocytes, may generate the transient outward potassium current I(To) (By similarity). In neurons, may conduct the transient subthreshold somatodendritic A-type potassium current (ISA) (By sim

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemmaCell projection, dendrite

VIAS BIOLÓGICAS (2)
Phase 1 - inactivation of fast Na+ channelsVoltage gated Potassium channels
MECANISMO DE DOENÇA

Spinocerebellar ataxia 19

A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA19 is a relatively mild, cerebellar ataxic syndrome with cognitive impairment, pyramidal tract involvement, tremor and peripheral neuropathy, and mild atrophy of the cerebellar hemispheres and vermis.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
62.6 TPM
Cerebelo
56.0 TPM
Brain Frontal Cortex BA9
23.7 TPM
Córtex cerebral
19.4 TPM
Esôfago - Muscular
16.0 TPM
OUTRAS DOENÇAS (3)
spinocerebellar ataxia type 19/22Brugada syndrome 9Brugada syndrome
HGNC:6239UniProt:Q9UK17
KCNE5Potassium voltage-gated channel subfamily E regulatory beta subunit 5Candidate gene tested inDesconhecido
FUNÇÃO

Potassium channel ancillary subunit that is essential for generation of some native K(+) currents by virtue of formation of heteromeric ion channel complex with voltage-gated potassium (Kv) channel pore-forming alpha subunits. Functions as an inhibitory beta-subunit of the repolarizing cardiac potassium ion channel KCNQ1

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
Phase 3 - rapid repolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

AMME complex

An X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, intellectual disability, midface hypoplasia and elliptocytosis.

EXPRESSÃO TECIDUAL(Tecido-específico)
Substância negra
12.7 TPM
Cerebelo
7.5 TPM
Hipotálamo
7.3 TPM
Brain Nucleus accumbens basal ganglia
6.8 TPM
Brain Caudate basal ganglia
5.7 TPM
OUTRAS DOENÇAS (2)
Brugada syndromeAlport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome
HGNC:6241UniProt:Q9UJ90
RANGRFRan guanine nucleotide release factorCandidate gene tested inTolerante
FUNÇÃO

May regulate the intracellular trafficking of RAN (PubMed:11290418). Promotes guanine nucleotide release from RAN and inhibits binding of new GTP by preventing the binding of the RAN guanine nucleotide exchange factor RCC1 (PubMed:29040603). Regulates the levels of GTP-bound RAN in the nucleus, and thereby plays a role in the regulation of RAN-dependent mitotic spindle dynamics (PubMed:29040603). Enhances the expression of SCN5A at the cell membrane in cardiomyocytes (PubMed:18184654, PubMed:216

LOCALIZAÇÃO

NucleusCytoplasm, perinuclear regionCytoplasmCell membrane

VIAS BIOLÓGICAS (1)
Phase 0 - rapid depolarisation
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
74.5 TPM
Cervix Endocervix
37.0 TPM
Útero
36.9 TPM
Fallopian Tube
35.1 TPM
Ovário
33.5 TPM
OUTRAS DOENÇAS (1)
Brugada syndrome
HGNC:17679UniProt:Q9HD47
GPD1LGlycerol-3-phosphate dehydrogenase 1-like proteinCandidate gene tested inTolerante
FUNÇÃO

Plays a role in regulating cardiac sodium current; decreased enzymatic activity with resulting increased levels of glycerol 3-phosphate activating the DPD1L-dependent SCN5A phosphorylation pathway, may ultimately lead to decreased sodium current; cardiac sodium current may also be reduced due to alterations of NAD(H) balance induced by DPD1L

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Synthesis of PA
MECANISMO DE DOENÇA

Brugada syndrome 2

A tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
101.9 TPM
Artéria tibial
81.9 TPM
Coração - Átrio
73.8 TPM
Bladder
73.2 TPM
Coração - Ventrículo esquerdo
62.8 TPM
OUTRAS DOENÇAS (2)
Brugada syndrome 2Brugada syndrome
HGNC:28956UniProt:Q8N335
CACNB2Voltage-dependent L-type calcium channel subunit beta-2Candidate gene tested inTolerante
FUNÇÃO

Beta subunit of voltage-dependent calcium channels which contributes to the function of the calcium channel by increasing peak calcium current (By similarity). Plays a role in shifting voltage dependencies of activation and inactivation of the channel (By similarity). May modulate G protein inhibition (By similarity). May contribute to beta-adrenergic augmentation of Ca(2+) influx in cardiomyocytes, thereby regulating increases in heart rate and contractile force (PubMed:36424916). Involved in m

LOCALIZAÇÃO

Cell membrane, sarcolemma

VIAS BIOLÓGICAS (3)
Presynaptic depolarization and calcium channel openingRegulation of insulin secretionAdrenaline,noradrenaline inhibits insulin secretion
MECANISMO DE DOENÇA

Brugada syndrome 4

A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset.

OUTRAS DOENÇAS (2)
Brugada syndrome 4Brugada syndrome
HGNC:1402UniProt:Q08289
AKAP9A-kinase anchor protein 9Candidate gene tested inTolerante
FUNÇÃO

Scaffolding protein that assembles several protein kinases and phosphatases on the centrosome and Golgi apparatus. Required to maintain the integrity of the Golgi apparatus (PubMed:10202149, PubMed:15047863). Required for microtubule nucleation at the cis-side of the Golgi apparatus (PubMed:15047863, PubMed:19242490). Required for association of the centrosomes with the poles of the bipolar mitotic spindle during metaphase (PubMed:25657325). In complex with PDE4DIP isoform 13/MMG8/SMYLE, recruit

LOCALIZAÇÃO

Golgi apparatusCytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome

VIAS BIOLÓGICAS (9)
Recruitment of mitotic centrosome proteins and complexesLoss of proteins required for interphase microtubule organization from the centrosomeLoss of Nlp from mitotic centrosomesRegulation of PLK1 Activity at G2/M TransitionAURKA Activation by TPX2
MECANISMO DE DOENÇA

Long QT syndrome 11

A heart disorder characterized by a prolonged QT interval on the ECG and polymorphic ventricular arrhythmias. They cause syncope and sudden death in response to exercise or emotional stress, and can present with a sentinel event of sudden cardiac death in infancy.

OUTRAS DOENÇAS (3)
long QT syndrome 11Brugada syndromefamilial long QT syndrome
HGNC:379UniProt:Q99996
CACNA1CVoltage-dependent L-type calcium channel subunit alpha-1CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming, alpha-1C subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents (PubMed:12181424, PubMed:15454078, PubMed:15863612, PubMed:16299511, PubMed:17224476, PubMed:20953164, PubMed:23677916, PubMed:24728418, PubMed:26253506, PubMed:27218670, PubMed:29078335, PubMed:29742403, PubMed:30023270, PubMed:30172029, PubMed:34163037, PubMed:8099908). Mediates influx of calcium ions into the cytoplasm, and thereby triggers calcium release from the sarcoplasm (By sim

LOCALIZAÇÃO

Cell membraneCell membrane, sarcolemmaPerikaryonPostsynaptic density membraneCell projection, dendriteCell membrane, sarcolemma, T-tubule

VIAS BIOLÓGICAS (5)
NCAM1 interactionsRegulation of insulin secretionAdrenaline,noradrenaline inhibits insulin secretionPhase 0 - rapid depolarisationPhase 2 - plateau phase
MECANISMO DE DOENÇA

Timothy syndrome

Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism.

OUTRAS DOENÇAS (10)
Timothy syndromelong QT syndrome 8Brugada syndrome 3neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
HGNC:1390UniProt:Q13936
SCNN1AEpithelial sodium channel subunit alphaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

This is one of the three pore-forming subunits of the heterotrimeric epithelial sodium channel (ENaC), a critical regulator of sodium balance and fluid homeostasis (PubMed:30251954, PubMed:32729833, PubMed:8023962, PubMed:8278374, PubMed:9792722). ENaC operates in epithelial tissues, where it mediates the electrodiffusion of sodium ions from extracellular fluid through the apical membrane of cells, with water following osmotically (PubMed:24124190, PubMed:28710092, PubMed:8278374). It plays a ke

LOCALIZAÇÃO

Apical cell membraneCell projection, ciliumCytoplasmic granuleCytoplasmCytoplasmic vesicle, secretory vesicle, acrosomeCell projection, cilium, flagellum

VIAS BIOLÓGICAS (2)
Stimuli-sensing channelsSensory perception of salty taste
MECANISMO DE DOENÇA

Pseudohypoaldosteronism 1B1, autosomal recessive

A form of pseudohypoaldosteronism type 1, a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. The disorder affects multiple organs, and is characterized by an often fulminant presentation in the neonatal period with dehydration, hyponatremia, hyperkalemia, metabolic acidosis, failure to thrive and weight loss.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula salivar
160.4 TPM
Rim - Medula
137.4 TPM
Esôfago - Mucosa
129.2 TPM
Tireoide
128.6 TPM
Pulmão
77.2 TPM
OUTRAS DOENÇAS (6)
pseudohypoaldosteronism, type IB1, autosomal recessivebronchiectasis with or without elevated sweat chloride 2Liddle syndrome 3Liddle syndrome
HGNC:10599UniProt:P37088
HCN4Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4Candidate gene tested inRestrito
FUNÇÃO

Hyperpolarization-activated ion channel that are permeable to Na(+) and K(+) ions with very slow activation and inactivation (PubMed:10228147, PubMed:10430953, PubMed:20829353). Exhibits higher selectivity for K(+) over Na(+) ions (PubMed:10228147). Contributes to the native pacemaker currents in heart (If) that regulate the rhythm of heart beat (Probable) (PubMed:10228147, PubMed:16407510, PubMed:19165230). Contributes to the native pacemaker currents in neurons (Ih) (Probable). May mediate res

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (1)
HCN channels
MECANISMO DE DOENÇA

Sick sinus syndrome 2

The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors. SSS2 onset is in utero or at birth.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
19.6 TPM
Coração - Átrio
8.0 TPM
Coração - Ventrículo esquerdo
2.8 TPM
Hipotálamo
1.6 TPM
Cerebelo
1.1 TPM
OUTRAS DOENÇAS (5)
sick sinus syndrome 2, autosomal dominantBrugada syndrome 8Brugada syndromefamilial sick sinus syndrome
HGNC:16882UniProt:Q9Y3Q4
SCN5ASodium channel protein type 5 subunit alphaDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Pore-forming subunit of Nav1.5, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient.

LOCALIZAÇÃO

Cell membraneCytoplasm, perinuclear regionCell membrane, sarcolemma, T-tubuleCell junction

VIAS BIOLÓGICAS (2)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisation
MECANISMO DE DOENÇA

Progressive familial heart block 1A

A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
36.1 TPM
Coração - Ventrículo esquerdo
35.1 TPM
Cervix Ectocervix
5.3 TPM
Cervix Endocervix
4.1 TPM
Nervo tibial
2.9 TPM
OUTRAS DOENÇAS (16)
progressive familial heart block, type 1Aventricular fibrillation, paroxysmal familial, type 1sick sinus syndrome 1long QT syndrome 3
HGNC:10593UniProt:Q14524
SCN2BSodium channel regulatory subunit beta-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes (PubMed:19808477, PubMed:23559163, PubMed:26894959, PubMed:30765605, PubMed:30765606, PubMed:35277491, PubMed:36823201). Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they all

LOCALIZAÇÃO

Cell membraneCell projection, axon

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Atrial fibrillation, familial, 14

A familial form of atrial fibrillation, a common sustained cardiac rhythm disturbance. Atrial fibrillation is characterized by disorganized atrial electrical activity and ineffective atrial contraction promoting blood stasis in the atria and reduces ventricular filling. It can result in palpitations, syncope, thromboembolic stroke, and congestive heart failure.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
97.1 TPM
Cerebelo
85.3 TPM
Brain Frontal Cortex BA9
54.0 TPM
Córtex cerebral
45.4 TPM
Brain Nucleus accumbens basal ganglia
33.1 TPM
OUTRAS DOENÇAS (3)
atrial fibrillation, familial, 14Brugada syndromefamilial atrial fibrillation
HGNC:10589UniProt:O60939
PKP2Plakophilin-2Candidate gene tested inTolerante
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25208567). Regulates focal adhesion turnover resulting in changes in focal adhesion size, cell adhesion and cell spreading, potentially via transcriptional modulation of beta-integrins (PubMed:23884246). Required to maintain gingival epithelial barrier function (PubMed:34368962). Important component of the desmosome that is also required for localization of desmosome component pro

LOCALIZAÇÃO

NucleusCell junction, desmosomeCell junctionCytoplasm

VIAS BIOLÓGICAS (1)
Formation of the cornified envelope
MECANISMO DE DOENÇA

Arrhythmogenic right ventricular dysplasia, familial, 9

A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
66.9 TPM
Coração - Átrio
41.6 TPM
Glândula salivar
35.8 TPM
Ovário
20.1 TPM
Cólon transverso
19.3 TPM
OUTRAS DOENÇAS (6)
arrhythmogenic right ventricular dysplasia 9Brugada syndromefamilial isolated arrhythmogenic ventricular dysplasia, left dominant formfamilial isolated arrhythmogenic ventricular dysplasia, right dominant form
HGNC:9024UniProt:Q99959
TRPM4Transient receptor potential cation channel subfamily M member 4Candidate gene tested inTolerante
FUNÇÃO

Calcium-activated selective cation channel that mediates membrane depolarization (PubMed:12015988, PubMed:12842017, PubMed:29211723, PubMed:30528822). While it is activated by increase in intracellular Ca(2+), it is impermeable to it (PubMed:12015988). Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane (PubMed:12015988). It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, e

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulumGolgi apparatus

VIAS BIOLÓGICAS (2)
TRP channelsSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Progressive familial heart block 1B

A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon transverso
69.4 TPM
Próstata
61.3 TPM
Skin Sun Exposed Lower leg
47.5 TPM
Glândula salivar
45.2 TPM
Skin Not Sun Exposed Suprapubic
41.8 TPM
OUTRAS DOENÇAS (5)
progressive familial heart block type IBerythrokeratodermia variabilis et progressiva 6Brugada syndromeprogressive familial heart block
HGNC:17993UniProt:Q8TD43
SCN1BSodium channel regulatory subunit beta-1Candidate gene tested inModerado
FUNÇÃO

Regulatory subunit of multiple voltage-gated sodium (Nav) channels directly mediating the depolarization of excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provoke

LOCALIZAÇÃO

Cell membranePerikaryonCell projectionCell projection, axonSecreted

VIAS BIOLÓGICAS (3)
Interaction between L1 and AnkyrinsPhase 0 - rapid depolarisationSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Generalized epilepsy with febrile seizures plus 1

A rare autosomal dominant, familial condition with incomplete penetrance and large intrafamilial variability. Patients display febrile seizures persisting sometimes beyond the age of 6 years and/or a variety of afebrile seizure types. This disease combines febrile seizures, generalized seizures often precipitated by fever at age 6 years or more, and partial seizures, with a variable degree of severity.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
166.3 TPM
Cérebro - Hemisfério cerebelar
165.4 TPM
Músculo esquelético
108.1 TPM
Brain Frontal Cortex BA9
81.3 TPM
Córtex cerebral
67.1 TPM
OUTRAS DOENÇAS (11)
generalized epilepsy with febrile seizures plus, type 1developmental and epileptic encephalopathy, 52Brugada syndrome 5atrial fibrillation, familial, 13
HGNC:10586UniProt:Q07699
SLMAPSarcolemmal membrane-associated proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Associates with the striatin-interacting phosphatase and kinase (STRIPAK) core complex, forming the extended (SIKE1:SLMAP)STRIPAK complex (PubMed:29063833, PubMed:30622739). The (SIKE1:SLMAP)STRIPAK complex dephosphorylates STK3 leading to the inhibition of Hippo signaling and the control of cell growth (PubMed:29063833, PubMed:30622739). May play a role during myoblast fusion (By similarity)

LOCALIZAÇÃO

Cell membrane, sarcolemmaCytoplasm, myofibril, sarcomere, M lineCytoplasm, myofibril, sarcomere, Z lineCytoplasm, cytoskeleton, microtubule organizing center, centrosomeEndoplasmic reticulum membraneMitochondrion membrane

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
65.6 TPM
Artéria tibial
64.5 TPM
Esôfago - Muscular
57.3 TPM
Esôfago - Junção
52.2 TPM
Aorta
41.2 TPM
OUTRAS DOENÇAS (1)
Brugada syndrome
HGNC:16643UniProt:Q14BN4

Variantes genéticas (ClinVar)

406 variantes patogênicas registradas no ClinVar.

🧬 SLMAP: NM_001377540.1(SLMAP):c.1300+71A>G ()
🧬 SLMAP: NM_001377540.1(SLMAP):c.1903C>T (p.Arg635Trp) ()
🧬 SLMAP: NC_000003.11:g.(?_57843440)_(58520833_?)del ()
🧬 SLMAP: GRCh37/hg19 3p21.2-14.2(chr3:51149374-59265315)x1 ()
🧬 SLMAP: NM_001377540.1(SLMAP):c.1112A>G (p.Asn371Ser) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 7,756 variantes classificadas pelo ClinVar.

5041
2715
VUS (65.0%)
Benigna (35.0%)
VARIANTES MAIS SIGNIFICATIVAS
SCN5A: NM_000335.5(SCN5A):c.3674A>T (p.Asp1225Val) [Uncertain significance]
HCN4: NM_005477.3(HCN4):c.2648C>T (p.Pro883Leu) [Uncertain significance]
SCN10A: NM_006514.4(SCN10A):c.3715G>C (p.Glu1239Gln) [Uncertain significance]
SCN10A: NM_006514.4(SCN10A):c.4281+6T>C [Uncertain significance]
SCN1B: NM_001037.5(SCN1B):c.448+49G>C [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 21
·Pré-clínico19
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome Brugada

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

8 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

54 ensaios clínicos encontrados, 13 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
2.402 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 2.402

#1

Sodium Channel Isoform Diversity Underlies Chamber-Specific Cardiac Excitability.

Circulation research2026 Mar 25

NaV (voltage-gated sodium) channels drive cardiac excitability. Although NaV1.5 is the primary cardiac isoform, the composition and functional contributions of non-NaV1.5 isoforms in the heart remain unclear. Here, we developed a chemical-genetic mouse model (NaV1.5GX/GX) in which NaV1.5 can be selectively and reversibly inhibited by acyl- and aryl-sulfonamide compounds (GX [acyl- and aryl-sulfonamide compounds typically denoted by the name GX-### and associated items] drugs). Cardiac activity was assessed by electrocardiograms in vivo, and optical mapping was used for imaging of ex vivo hearts. Whole-cell voltage-clamp in tandem with validated toxins and isoform-selective inhibitors were used to examine sodium current composition. NaV1.5GX/GX mice exhibited normal cardiac function at baseline, but acute GX drug administration caused profound conduction defects and arrhythmias. Whole-heart optical mapping revealed dose-dependent chamber-specific sensitivity to NaV1.5 inhibition, with the right ventricle being the most sensitive, followed by the left ventricle, left atrium, and right atrium. Patch-clamp recordings of isolated cardiomyocytes with application of NaV isoform-selective inhibitors showed that NaV1.5 contributed 93% of sodium current in the left ventricle, 79% in the right ventricle, and 78% in the atria. Non-NaV1.5 isoforms were differentially enriched across chambers: NaV1.8 in the left ventricle, NaV1.1/1.3 in the right ventricle, and NaV1.2/1.6/1.7 in the atria. These results reveal a surprising chamber-specific isoform landscape of cardiac sodium currents, which may underlie the right ventricular predominant phenotype of Brugada syndrome. These data highlight non-NaV1.5 isoforms as potential mediators of chamber-specific cardiac pathologies and as pharmacological targets.

#2

Unmasking Brugada syndrome: a case report of diagnostic oversights.

European heart journal. Case reports2026 Mar

Brugada syndrome (BrS) is an unusual cardiac channelopathy associated with an increased risk of ventricular fibrillation (VF) and sudden cardiac death (SCD), highlighting the critical importance of early diagnosis. A 22-year-old male patient presented with recurrent episodes of syncope, palpitations, and dyspnoea. Initial electrocardiograms (ECGs) showing a Brugada Type 1 pattern were misinterpreted as incomplete right bundle branch blocks. The patient was erroneously diagnosed with epilepsy due to misinterpretation of his syncope episodes as seizures. After further investigations, including a propafenone provocation test and cardiac magnetic resonance imaging (MRI), BrS was confirmed. An electrophysiologic study showed no inducibility of ventricular tachycardia (VT) or VF, and a subcutaneous implantable cardioverter-defibrillator (S-ICD) was implanted for the prevention of SCD. The patient's recovery was successful and uncomplicated. Brugada syndrome patients usually present with SCD, syncope, or severe arrhythmias. Syncope is the most common clinical presentation and identifies patients who could benefit from ICD. Only the Type 1 Brugada pattern is diagnostic, either spontaneous, unmasked by high precordial leads, or by sodium channel inhibition. Implantable cardioverter-defibrillator placement is indicated to prevent SCD. A subcutaneous defibrillator should be considered if the patient has no need for anti-bradyarrhythmia pacing. Early recognition of BrS in patients with syncope is critical, especially for first-line providers interpreting ECGs, as it may prevent SCD.

#3

Clinical profile and prognosis of brugada syndrome SCN5A variant carriers with negative sodium channel blocker challenge.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026 Mar 10

Loss-of-function (LOF) variants in SCN5A are associated with Brugada syndrome (BrS), progressive conduction slowing, and other arrhythmias. While the prognosis of SCN5A carriers with a positive sodium channel blocker challenge (SCBC) is established, data on those with negative SCBC are limited. To assess the clinical presentation and prognosis of SCN5A variant carriers with negative SCBC, and compare them to relatives with positive SCBC. We retrospectively included patients from five university hospitals (2000-2024) carrying a pathogenic or likely pathogenic SCN5A variant and negative SCBC. Relatives with the same variant and positive SCBC were also analysed. Patients with spontaneous type 1 ECG, gain-of-function variants, double variants, or ACMG class 1-3 variants were excluded. Clinical, ECG, genetic, and follow-up data were collected. Conduction slowing was evaluated using the PR interval and QRS duration. The cohort included 162 patients from 43 families (median age 37 ± 19 years, 46% male), of whom 69 (43%) had negative SCBC. Among these 69 patients, 25 (36%) had baseline intraventricular conduction defects, and 19 (28%) had first-degree AV block. After a median follow-up of 75 [40-168] months, 52% of patients developed progressive conduction slowing. Negative SCBC patients had fewer conduction defects (36% vs. 70%, p = 0.002) and ICD implantations (1% vs. 23%, P < 0.001). Non-missense variants were associated with more conduction slowing (71% vs. 42%, P = 0.04). This multicentre study provides the largest analysis of SCN5A carriers with negative SCBC, showing excellent arrhythmic prognosis despite frequent progressive conduction slowing.

#4

Paediatric inherited arrhythmia clinic: developing a new model of care.

BMJ paediatrics open2026 Mar 09

To describe the development and utilisation of a paediatric inherited arrhythmia clinic (IAC) from 2014 to 2024, including service developments following the introduction of cardiac genetic coordinators (CGC). Retrospective cohort study. The IAC at Children's Hospital Westmead, New South Wales, Australia (approximately 8 million people). Children (aged 0-18 years) referred to the IAC. Clinical and genetic data were extracted and analysed. Description of the development and cohort of the clinic. A monthly clinic preceded by a team meeting (multidisciplinary team) led by a paediatric cardiologist and clinical geneticist was established. Attendees included a genetic counsellor, senior arrhythmia nurse and clinical psychologist.A total of 301 individuals aged 0-18 years were seen over 11 years: 32 in 2014 and 128 in 2024. 85 probands presented with cardiac arrest (37; 44%), syncope (23; 27%) and others (25; 29%). The most common diagnoses were Long QT syndrome 33 (38%), catecholaminergic polymorphic ventricular tachycardia 24 (28%) and Brugada syndrome 6 (7%). 226/301 children had genetic testing; pathogenic/likely pathogenic variants were found in 173/226 (77%), including 121 family members. The most common genes implicated were KCNQ1 (67), KCNH2 (39), SCN5A (28) and RyR2 (15).Dedicated allied health/nursing CGCs appointed in 2023 improved the collation of clinical/family data (particularly new referrals), links to adult cardiology, forensic and regional genetic and paediatric services. The multidisciplinary IAC achieves the phenotyping, genotyping and holistic care of large numbers of children, mostly with cardiac ion channelopathies. Dedicated coordinators provided an incremental improvement to the service.

#5

Inappropriate ICD shock occurred 34 years after the last syncope in a symptomatic Brugada patient: does arrhythmia risk shift from VF to AF with age in Brugada syndrome?

BMJ case reports2026 Feb 25

Atrial fibrillation (AF) is a significant cause of inappropriate implantable cardioverter defibrillator (ICD) shocks. A male patient in his 70s was diagnosed with Brugada syndrome (BrS) in his 40s following ventricular fibrillation-induced syncope. He had implanted a single-lead ICD in his 50s. 34 years after the last syncope, the ICD delivered four inappropriate shocks due to paroxysmal AF, successfully treated with pulmonary vein isolation. Ageing likely increased AF burden, despite its infrequency during follow-up. This case highlights the limitations of single-lead ICDs in AF detection and the importance of tailored management in elderly BrS patients.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC2.721 artigos no totalmostrando 195

2026

Sodium Channel Isoform Diversity Underlies Chamber-Specific Cardiac Excitability.

Circulation research
2026

Beyond Common Arrhythmias: Discovering Brugada Syndrome in a Patient With Nonspecific Symptoms.

Cureus
2026

Brugada Syndrome Unmasked by Fever: A Rare Cause of ST-Segment Elevation.

Journal of acute medicine
2026

Unmasking Brugada syndrome: a case report of diagnostic oversights.

European heart journal. Case reports
2026

Predictive Value of Notched P Wave for Life-Threatening Arrhythmias in Patients with Brugada Syndrome: Insights from a Multicenter Prospective Study.

Heart rhythm
2026

Clinical profile and prognosis of brugada syndrome SCN5A variant carriers with negative sodium channel blocker challenge.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2026

Paediatric inherited arrhythmia clinic: developing a new model of care.

BMJ paediatrics open
2026

Characterization of the R893C NaV1.5 mutation in Brugada syndrome.

Frontiers in cardiovascular medicine
2026

Magnetic field based investigation of Brugada syndrome.

European biophysics journal : EBJ
2026

Safety of Intranasal Esketamine Administration in Brugada Syndrome: Two Clinical Case Reports.

Journal of clinical psychopharmacology
2026

Prognostic Value of Small Coved-Type ST-Segment Area in Patients With Spontaneous Type 1 Brugada Syndrome.

Journal of cardiovascular electrophysiology
2026

Low Arrhythmic Risk in Individuals With Brugada ECG Pattern and a Negative dST-Tiso Criterion.

The American journal of cardiology
2026

Brugada Syndrome Unmasked by Kratom Use in a Young Man.

JACC. Case reports
2026

Inappropriate ICD shock occurred 34 years after the last syncope in a symptomatic Brugada patient: does arrhythmia risk shift from VF to AF with age in Brugada syndrome?

BMJ case reports
2026

AI-ECG classification for Brugada syndrome: A study of machine learning techniques to optimise for limited datasets.

PLOS digital health
2026

[Cardiogenetics in Piacenza: integrated care and telemedicine for precision medicine].

Giornale italiano di cardiologia (2006)
2026

Contemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement.

Journal of arrhythmia
2026

Unmasking Brugada ECG Pattern in Myotonic Dystrophy Type 2 With an ANK2 Variant.

Pacing and clinical electrophysiology : PACE
2026

Propafenone Overdose Presenting With Brugada Phenocopy, QRS Widening, and Ventricular Fibrillation.

JACC. Case reports
2025

An unexpected diagnosis: Brugada Syndrome in a healthy Kenyan male athlete.

Cardiovascular journal of Africa
2026

Dental drugs with proarrhythmic risk in patients with Brugada syndrome: precaution instructions for practices in the field of orofacial pain.

Frontiers in cardiovascular medicine
2026

A case report of J wave syndrome with abnormal potentials in both right and left ventricles and reversed J wave in lead V1.

European heart journal. Case reports
2025

Brugada syndrome risk scores: what we've learned and what's next.

Frontiers in cardiovascular medicine
2026

Accuracy of final-year paramedic students' ECG interpretation and referrals for transient loss of consciousness, per the NICE CG109 guidelines.

Advances in physiology education
2026

[Cardiac arrhythmias-Cellular mechanisms, consequences and challenges in the diagnostics using human models].

Herz
2026

Photoswitches for ion channel regulation: expanding the scope of phototherapy through computational chemistry.

Physical chemistry chemical physics : PCCP
2026

Exploration of the Role of Cilostazol in Brugada Syndrome: Mechanisms, Therapeutic Potential, and Implications in the Prevention of Ventricular Arrhythmias.

Reviews in cardiovascular medicine
2026

Selectivity Filter Mutation in NaV1.5 Promotes Ventricular Tachycardia.

JACC. Clinical electrophysiology
2026

Programming optimization is crucial for minimizing inappropriate shocks in patients with Brugada syndrome with a subcutaneous implantable cardioverter-defibrillator.

European heart journal
2026

Inappropriate shocks in Brugada syndrome: a matter of data capture rather than programming?

European heart journal
2026

Association between epicardial adipose tissue characteristics and ventricular fibrillation in Brugada syndrome.

Heart rhythm
2026

[Sudden death recovered: Brugada syndrome, a wolf in sheep's clothing].

Medicina
2026

Efficacy and Safety of Radiofrequency Catheter Ablation in Brugada syndrome: A Systematic Review and Meta-Analysis.

Critical pathways in cardiology
2026

Diagnosis and management of Brugada Syndrome Unmasked by Flecainide challenge in a patient with unexplained ventricular fibrillation: a case report.

Oxford medical case reports
2026

Intravenous anesthesia using remimazolam for a patient with Brugada Syndrome.

Minerva anestesiologica
2026

Brugada syndrome following acute bupropion overdose in a pediatric patient.

Clinical toxicology (Philadelphia, Pa.)
2026

Clinical Spectrum of Arrhythmogenic Entities in Spanish Children Carrying Deleterious SCN5A Variants.

International journal of molecular sciences
2026

Phenotypic Severity of SCN5A-Related Bradycardia Is Independent of Dominant-Negative and Coupled Gating Effects.

Circulation. Arrhythmia and electrophysiology
2026

Initial experience with the extravascular implantable cardioverter-defibrillator: Workflow, feasibility and safety.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
2026

Brugada Syndrome: New Implications for Heterozygous Carriers of the Pathogenic SCN5A c.689T>C(p.Ile230Thr) Variant.

American journal of medical genetics. Part A
2026

Exercise stress test unmasking a Brugada pattern in a survivor of cardiac arrest: a case report.

European heart journal. Case reports
2025

Extravascular implantable cardioverter-defibrillator implantation in a teenager with Brugada syndrome and recurrent inappropriate shocks of subcutaneous implantable cardioverter-defibrillator.

HeartRhythm case reports
2025

A CACNB2b variant causing reduced CaV1.2 current in monozygotic twin brothers with Brugada syndrome.

HeartRhythm case reports
2026

Supraventricular tachycardias in ion channel diseases.

Herzschrittmachertherapie &amp; Elektrophysiologie
2026

The establishment of a GPD1L knockout human embryonic stem cell line (WAe009-A-80) using the CRISPR/Cas9 system.

Stem cell research
2026

Case series of Type 1 Brugada pattern provoked by exercise: a role for diagnostic treadmill stress testing.

European heart journal. Case reports
2026

Anaesthetic management of a pregnant woman with Brugada syndrome undergoing Caesarean section: a case report.

BMC anesthesiology
2026

Yield of regular practice of high precordial leads electrocardiogram among asymptomatic upper Egyptian population considering Brugada patterns, a cross-sectional study.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
2026

Finding a new rhythm: child health-related quality of life, parent psychological distress, and unmet needs among families of children with cardiac channelopathies.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
2025

COVID-19-induced Brugada phenocopy pattern in a patient with previous myocardial infarction: A case report.

Medicine
2025

The Utility of Genome-Wide Association Studies in Inherited Arrhythmias and Cardiomyopathies.

Genes
2025

Current perspectives on risk prediction and genetic basis of Brugada syndrome.

Frontiers in cardiovascular medicine
2025

MOG1L18F-mediated increase in late sodium current produces Long QT Syndrome.

medRxiv : the preprint server for health sciences
2025

Brugada Phenocopy in Hypothyroidism.

CJC open
2025

Impact of physical activity on presentation and prognosis of Brugada syndrome.

Open heart
2025

In vivo mapping of human polymorphic ventricular tachycardia.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
2026

Geographic variations in the prevalence of inherited cardiac diseases and in the incidence of related sudden death.

International journal of cardiology
2025

Multidisciplinary care of kidney donation in Brugada syndrome: A case report.

World journal of transplantation
2025

Current Perspective for Atrial Fibrillation in Patients with Brugada Syndrome: A Comprehensive Review.

Reviews in cardiovascular medicine
2026

ECG Markers of Positive Drug Challenge With Ajmaline in Patients With Brugada Syndrome.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2026

Safety, Utility, and Outcomes of Procainamide Challenge for the Diagnosis and Exclusion of Brugada Syndrome.

Circulation
2025

Chronic kratom use as a precipitant for acquired Brugada syndrome.

HeartRhythm case reports
2025

Epidemiology of paediatric inherited arrhythmogenic diseases under "Real World" conditions: findings from a 10-year longitudinal study in Eastern Austria.

European journal of pediatrics
2026

The Role of Quinine to Prevent Ventricular Fibrillation and ICD Shocks in Early Repolarization Syndrome.

JACC. Case reports
2025

Oxaliplatin and amlodipine combination induced reversible Brugada phenocopy: A case report.

Medicine
2025

Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCs.

Stem cell research &amp; therapy
2025

N-palmitoyl glycine differentially modulates TRPM4 and TRPC5 and is causally linked to Brugada syndrome.

Communications biology
2025

Generation of a homozygous and heterozygous iPSC line carrying a variant of uncertain significance in CACNA1C, associated with Brugada syndrome.

Stem cell research
2025

Clinical presentation and outcomes of patients with biallelic SCN5A variants: A systematic review.

Heart rhythm O2
2025

A SCN5A gene mutation (c.1768 A>C, p.K590Q) in a patient with Brugada syndrome: a case report.

American journal of translational research
2025

Biphasic effects on human atrial arrhythmogenicity of L-type calcium channel mutations associated with a Brugada/Short QT overlap syndrome - insights from a multiscale simulation study.

PLoS computational biology
2025

Automated patch clamp data improve variant classification and penetrance stratification for SCN5A-Brugada syndrome.

European heart journal
2026

Real-world pharmacovigilance and clinical risks of fluvoxamine: A disproportionality analysis based on FAERS data.

Journal of affective disorders
2026

Time to Benefit of Epicardial Ablation in Malignant Forms of Brugada Syndrome: A Reconstructed Individual Patient Data Meta-Analysis.

Journal of cardiovascular electrophysiology
2025

Brugada Syndrome: an exemplar for the genomic basis of sudden death.

European journal of human genetics : EJHG
2025

Hybrid mini-thoracotomy for Brugada syndrome: epicardial substrate characterization and ablation-results from UNCOVER(BrS) study.

Frontiers in cardiovascular medicine
2025

Unmasking Type 1 Brugada Pattern Following Pilsicainide Administration for Paroxysmal Atrial Fibrillation: A Case Report.

JMA journal
2025

Coupling of USP10 de-ubiquitination and chaperone-mediated autophagy causes cardiac sodium channel degradation and cardiac arrhythmias.

Cardiovascular research
2026

Knowledge gaps and educational needs in the perioperative management of genetic arrhythmia syndromes: a survey of the American Society of Anesthesiologists.

British journal of anaesthesia
2025

Cardiac Channelopathies in the Pediatric Patient: Brugada Syndrome.

Cardiac electrophysiology clinics
2025

Sepsis related Brugada syndrome in community acquired pneumonia due to Legionella pneumophila: a case report.

BMC pulmonary medicine
2025

Fever, Syncope, and the Brugada Dilemma: Navigating the Complexities of ICD Decision-Making in an Atypical Presentation.

Case reports in cardiology
2025

Safe Anesthesia for Brugada Syndrome in Pregnancy: Insights From a Retrospective Case Series.

Cureus
2025

New mechanistic observation: Ajmaline-induced epicardial "zigzag" electrogram pattern in Brugada syndrome.

Heart rhythm
2025

High-density atrial mapping, P-wave analysis, and computational simulations in Brugada syndrome: Enhancing the understanding of atrial fibrillation.

Heart rhythm O2
2025

Gene Therapy for Inherited Cardiac Arrhythmias.

Journal of cardiovascular translational research
2025

Impact of Atrial Fibrillation on the Outcome of Patients with Brugada Syndrome: A Meta-Analysis.

Journal of cardiovascular development and disease
2025

Brugada syndrome diagnosed in a young woman occurring postpartum: case report and literature review.

Frontiers in cardiovascular medicine
2025

Integrated Genomic Approaches to Elucidate the Genetic Basis of Brugada Syndrome in Taiwanese Patients.

Bioinformatics and biology insights
2025

[Research progress on cardiac L-type calcium channel mutations in Brugada syndrome and early repolarization syndrome].

Zhonghua xin xue guan bing za zhi
2025

Epigenetic regulation of electromechanical continuity might determine phenotypic heterogeneity in SCN5A mutation carriers in Brugada syndrome.

Scientific reports
2025

CRISPR/Cas9-Based Gene Editing for Correcting Inherited Channelopathies.

Cardiology in review
2025

Beyond the sodium channel: Proteomic clues to the Brugada syndrome substrate.

Heart rhythm
2025

Characterization of a Splice-Altering Variant in SCN5A Associated With Brugada Syndrome - Insights Into Splice Error Correction.

Circulation journal : official journal of the Japanese Circulation Society
2025

Immune Checkpoint Inhibitor Myocarditis Masquerading as Brugada Syndrome.

JACC. Case reports
2025

Wnt/β-catenin signaling regulates cardiac Cx43 in a metabolic substrate-dependent manner.

Journal of molecular and cellular cardiology plus
2025

Genetic variants associated with ventricular arrhythmias during ajmaline test in Brugada syndrome.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Multiple anthropometric characteristics and Brugada syndrome: A Mendelian randomization study.

Medicine
2025

From blood to heartbeat: Plasma proteins and Brugada syndrome revealed by Mendelian randomization.

Heart rhythm
2026

Subcutaneous implantable cardiac defibrillator in Brugada syndrome: a prospective multicentre study.

European heart journal
2025

Low-dose oral flecainide provocation test for Brugada syndrome: a case series.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
2025

Accessory pathway unmasked by adenosine in a patient with unexplained cardiac arrest: a case report.

European heart journal. Case reports
2025

Novel Loss-of-Function Variant, Cys1384Phe, in SCN5A Is Associated With an Overlapping Phenotype of Brugada Syndrome, Sick Sinus Syndrome, and Dilated Cardiomyopathy.

Circulation journal : official journal of the Japanese Circulation Society
2025

Brugada Phenocopy in a Child With Parvovirus B19 Myocarditis.

JACC. Case reports
2025

Distinct patterns of ventricular fibrillation onset in primary electrical diseases: insights from a retrospective multicentre registry.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Brugada ECG Pattern in Wilson Disease: Genetic Coincidence or Triggered Phenocopy?

JACC. Case reports
2025

Predictive value of Shanghai score system in patients with drug-induced type 1 Brugada electrocardiographic pattern.

Clinical research in cardiology : official journal of the German Cardiac Society
2025

Methadone Blockade of Inward Rectifier Potassium Current Promotes Both Early and Delayed Repolarization Arrhythmias: Mechanistic Insights From Computational Modeling.

Journal of the American Heart Association
2025

Temperature-Induced ICD Malfunction in a Patient With Brugada Syndrome.

JACC. Case reports
2025

Pyrexia-Induced Brugada Syndrome Unmasked by Community-Acquired Pneumonia: A Case Report.

Cureus
2025

Bradycardia-Dependent Transient Rise in the Atrial Lead Capture Threshold 21 Years After the Lead Implantation.

Pacing and clinical electrophysiology : PACE
2025

Brugada ECG Pattern in A Caucasian Patient with Severe Hypothyroidism.

European journal of case reports in internal medicine
2025

Ranolazine-Induced Type 1 Brugada Pattern.

JACC. Case reports
2025

Functional validation of the Nav1.5/R1432G Brugada syndrome variant using a Nav1.5 knockout iPSC-derived cardiomyocyte model.

Biochemical and biophysical research communications
2025

Managing Brugada Syndrome in a Private Dental Practice: A Structured Case-Based Review.

Cureus
2025

Uncommon and Accessory Electrocardiographic Findings in Brugada Syndrome: A Review.

Journal of clinical medicine
2025

Resuscitated cardiac arrest due to Brugada syndrome in an Ethiopian man: a case report.

BMC cardiovascular disorders
2025

Catheter ablation to prevent malignant ventricular arrhythmias in symptomatic Brugada syndrome: A systematic review and meta-analysis.

Heart rhythm
2025

Brugada Syndrome and the Need for Device-Specific ICD Indications.

JACC. Clinical electrophysiology
2025

The Clinical Significance of Atrial Fibrillation in Non-High-Risk Brugada Syndrome: The BruFib Study.

JACC. Clinical electrophysiology
2025

Atrial Fibrillation in Brugada Syndrome: Sorting the Wheat From the Chaff.

JACC. Clinical electrophysiology
2025

Automated Assessment to Predict Lethal Arrhythmias in Brugada Syndrome: Significance of R' in Lead III.

Journal of arrhythmia
2025

Brugada syndrome in the forensic field: what do we know to date?

Frontiers in cardiovascular medicine
2025

Catheter Ablation vs. Standard Implantable Cardioverter Defibrillator Therapy in Symptomatic Brugada Syndrome: A Systematic Review and Meta-Analysis of Controlled Studies.

Medical sciences (Basel, Switzerland)
2025

Undiagnosed Brugada Syndrome Presenting as Ventricular Fibrillation Cardiac Arrest.

JACC. Case reports
2025

Multidisciplinary Care Approach to Asymptomatic Brugada Syndrome in Pregnancy: A Case Report.

Reports (MDPI)
2025

Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications.

Medical sciences (Basel, Switzerland)
2025

SNTA1-deficient human cardiomyocytes show shorter field potential duration and slower conduction velocity.

Scientific reports
2025

Beyond the Pleura: A Case Report of Type 1 Brugada Phenocopy in the Setting of Empyema.

Cureus
2025

A Classic Pattern of Type 1 Brugada Syndrome on Electrocardiogram.

QJM : monthly journal of the Association of Physicians
2025

How can we improve on selecting the appropriate therapy in Brugada syndrome?

Expert review of cardiovascular therapy
2025

Incessant Electrical Storm in a Patient With Brugada Syndrome Provoked by Previously Unreported Syndrome-Inducing Medication.

JACC. Case reports
2025

Searching for the Holy Grail in risk stratification in patients with Brugada syndrome.

Indian pacing and electrophysiology journal
2025

Usefulness of aVR sign as a predictor of sudden cardiac death or appropriate ICD shocks in Brugada syndrome: A systematic review and meta-analysis of cohort studies.

Indian pacing and electrophysiology journal
2025

A Comprehensive Review of a Mechanism-Based Ventricular Electrical Storm Management.

Journal of clinical medicine
2025

The role of adrenaline in comprehensive management of electrical storms in high-risk Brugada syndrome with rare SCN5A mutation: a case report from medical stabilization to implantable cardioverter-defibrillator implantation.

European heart journal. Case reports
2025

The Utility of Notched P-Wave on the Occurrence of Ventricular Fibrillation in Patients With Brugada Syndrome.

Journal of arrhythmia
2025

Beyond the type 1 pattern: comprehensive risk stratification in Brugada syndrome.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
2025

Management of channelopathies in children.

Herzschrittmachertherapie &amp; Elektrophysiologie
2025

Theory and Practice of Present Clinical Use of Quinidine in the Management of Cardiac Arrhythmias.

Indian pacing and electrophysiology journal
2025

Characterization of reflex syncope in Brugada syndrome: a literature review.

Journal of cardiovascular medicine (Hagerstown, Md.)
2025

Baseline quantitative ECG parameters do not fully predict class 1 antiarrhythmic effect in Brugada patient: Drug-induced ECG changes in Brugada patients.

Journal of electrocardiology
2026

Hypokalaemia and bradycardia unmask the loss-of-function phenotype of a Brugada Syndrome SCN5A mutation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Risk stratification of major arrhythmia events in Japanese patients with Brugada syndrome using machine learning models.

Heart rhythm O2
2025

Genetic Basis of Brugada Syndrome.

Biomedicines
2025

Sudden Cardiac Arrest and Death in Sports: An Updated Overview of Epidemiology, Etiologies, and Prevention Strategies, with Emphasis on Inherited Cardiomyopathies.

Seminars in thrombosis and hemostasis
2025

Management of Dental Demineralization in a Patient with Complex Medical Conditions: A Case Report and Clinical Outcomes.

Reports (MDPI)
2025

The Diagnostic Value of Copy Number Variants in Genetic Cardiomyopathies and Channelopathies.

Journal of cardiovascular development and disease
2026

A machine learning platform for genotype-specific cardiotoxicity risk prediction using patient-derived iPSC-CMs.

Journal of advanced research
2025

Inherited arrhythmia syndromes - Cardiogenetics.

Indian pacing and electrophysiology journal
2025

Synthetic electrocardiograms for Brugada syndrome: from data generation to expert cardiologists evaluation.

European heart journal. Digital health
2025

SCN5A mutation-associated sick sinus syndrome revealed by atrial flutter in a pediatric patient.

Journal of cardiology cases
2025

Regional Anesthesia in Brugada Syndrome-Worth the Risk? A Dual-Case Report.

A&amp;A practice
2025

Wide QRS monomorphic tachycardia induced by ajmaline infusion.

HeartRhythm case reports
2025

Fever as a Catalyst for Life-Threatening Arrhythmias in Brugada Syndrome: A Rare Case of Brugada Syndrome Unmasked in a Young Male.

Clinical case reports
2025

Accumulating evidence for epicardial ablation in malignant forms of Brugada syndrome: summary of two randomized clinical trials.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Portuguese National Registry on Cardiac Electrophysiology, 2021 and 2022.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology
2025

Optimizing C-Type Natriuretic Peptide and Receptor Expression Analysis with Droplet Digital™ PCR: Advancing Biomarker Discovery for Brugada Syndrome?

Biomolecules
2025

Safety of propofol use for general anaesthesia in Brugada syndrome patients: a 15-year experience.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Demographics, Clinical Features and Genetics of Common Inherited Arrhythmias in Oman.

Journal of the Saudi Heart Association
2025

Challenges in the treatment of patients with Brugada syndrome: The current role of ablation.

Kardiologia polska
2025

Brugada Phenocopy in a Critical Obstetric Patient: A Case Report.

Case reports in medicine
2025

Caveolin 3 Variant T78M in a Large Family With Brugada Syndrome: Clinical Features and Coexistence of ADRB1 and GRK5 Gene Mutation.

Journal of cardiovascular electrophysiology
2025

Characteristics of patients with Brugada syndrome and monomorphic ventricular tachycardia.

Heart rhythm
2025

Molecular mechanism for the interaction of MOG1 with the intracellular loop II of cardiac sodium channel Nav1.5 and its role in arrhythmias.

Journal of molecular and cellular cardiology
2025

Effects of Arrhythmias on the Mortality and Morbidity in Pediatric Patients With Seizure Disorders.

Pediatric neurology
2025

Dual pathology of lower urinary tract obstruction and Brugada syndrome: A rare cause of non-immune hydrops fetalis.

European journal of obstetrics, gynecology, and reproductive biology
2025

Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome.

Annals of hematology
2025

[Variations on a Brugada syndrome].

Atencion primaria
2025

Motor induced syncope after cerebral infarction: A case report and literature review.

SAGE open medical case reports
2025

Assessment of activation delay in the right ventricular outflow tract as a potential complementary diagnostic tool for Brugada Syndrome.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Diagnosing Brugada syndrome: look for right ventricular outflow tract conduction delay.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Updates on inherited arrhythmia syndromes (Brugada syndrome, long QT syndrome, CPVT, ARVC).

Progress in cardiovascular diseases
2025

Wide complex tachycardia and brugada electrocardiographic pattern induced by propafenone: A rare and unpredictable pro-arrhythmic effect.

Journal of electrocardiology
2025

Selectivity filter mutation in Na V 1.5 promotes ventricular tachycardia.

bioRxiv : the preprint server for biology
2025

Sumatriptan Induced Brugada Syndrome, a Rare Presentation of a Commonly Used Drug.

Clinical case reports
2026

A systematic review and meta-analysis of artificial intelligence ECGs performance in the diagnosis of Brugada Syndrome.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
2025

A case of Hyperkalemia-induced Brugada Phenocopy: a rare but serious electrocardiographic imposter.

Oxford medical case reports
2025

Decades of Defibrillation in Brugada Syndrome: Appropriate or Inappropriate?

JACC. Clinical electrophysiology
2025

Low Expression Levels of Sodium Channels in the Right Ventricular Outflow Tract Underly the Genesis of the Characteristic Electrocardiogram Waveform in Brugada Syndrome.

Circulation journal : official journal of the Japanese Circulation Society
2025

Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
2025

Syncope and "Normal" ECG: Is Brugada Syndrome the Culprit?

Cureus
2025

Pediatric arrhythmias: a comprehensive integrative review, symptom-based conceptual framework, and practical care guide.

Boletin medico del Hospital Infantil de Mexico
2025

[Pharmacogenetic exploration of genes associated with cardiac ion channel disease].

Zhonghua xin xue guan bing za zhi
2025

An NGS-based approach for precise and footprint-free CRISPR-based gene editing in human stem cells.

Methods (San Diego, Calif.)
2025

Understanding Brugada Pattern in Elderly Patients with COVID-19: A Case Study.

The American journal of case reports
2025

Sudden Cardiac Death in Pregnant Women-Literature Review and Autopsy Findings.

Diagnostics (Basel, Switzerland)
2025

Entrectinib-Induced Brugada Syndrome Leading to Ventricular Tachycardia in A Patient with ROS1 Fusion-Positive Lung Adenocarcinoma.

European journal of case reports in internal medicine
2026

Systematic triplet expansion testing in patients with genetically negative Brugada syndrome.

Revista espanola de cardiologia (English ed.)
2025

In silico modelling of multi-electrode arrays for enhancing cardiac drug testing on hiPSC-CM heterogeneous tissues.

The Journal of physiology
2025

Indication of Implantable Cardioverter Defibrillators for Ventricular Arrhythmias in Coronary Spastic Angina.

Pacing and clinical electrophysiology : PACE
2025

Long-term of epicardial radiofrequency ablation and benefit for recurrent ventricular arrhythmia in Brugada syndrome: A systematic review and meta-analysis.

Journal of arrhythmia
2025

Effectiveness of resveratrol in inducing adeno-associated virus as a potential definitive therapy for SCN5A mutation in Brugada syndrome: a narrative review.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
2025

Episodic long-lasting atrial standstill associated with an SCN5A variant resulting in atrial pacing failure: Is an atrial lead necessary for familial atrial standstill?

HeartRhythm case reports
2025

Multiparametric models for predicting major arrhythmic events in Brugada syndrome: a systematic review and critical appraisal.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Ver todos os 2.721 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome Brugada.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome Brugada

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Sodium Channel Isoform Diversity Underlies Chamber-Specific Cardiac Excitability.
    Circulation research· 2026· PMID 41878815mais citado
  2. Unmasking Brugada syndrome: a case report of diagnostic oversights.
    European heart journal. Case reports· 2026· PMID 41858704mais citado
  3. Clinical profile and prognosis of brugada syndrome SCN5A variant carriers with negative sodium channel blocker challenge.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology· 2026· PMID 41812135mais citado
  4. Paediatric inherited arrhythmia clinic: developing a new model of care.
    BMJ paediatrics open· 2026· PMID 41802778mais citado
  5. Inappropriate ICD shock occurred 34 years after the last syncope in a symptomatic Brugada patient: does arrhythmia risk shift from VF to AF with age in Brugada syndrome?
    BMJ case reports· 2026· PMID 41741125mais citado
  6. Making a Start: Discerning Ventricular Arrhythmia Initiation in Brugada Syndrome.
    JACC Clin Electrophysiol· 2026· PMID 41979548recente
  7. Clinical Profile and Mode of Initiation of Spontaneous Ventricular Tachyarrhythmias in Patients With Brugada Syndrome (START-BrS).
    JACC Clin Electrophysiol· 2026· PMID 41979546recente
  8. Dietary and emotional triggers of ventricular fibrillation in Brugada syndrome: insights from a long-term subcutaneous implantable cardioverter-defibrillator case report.
    AME Case Rep· 2026· PMID 41971914recente
  9. Real-world pharmacovigilance insights and clinical safety signal characterization of the classic mood stabilizer‑lithium carbonate: A disproportionality analysis based on FAERS data.
    J Affect Disord· 2026· PMID 41921879recente
  10. RYR1 Pathogenic Variant in a Patient With Overlapping Features of Brugada Syndrome and Arrhythmogenic Cardiomyopathy.
    JACC Case Rep· 2026· PMID 41914936recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:130(Orphanet)
  2. MONDO:0015263(MONDO)
  3. GARD:1030(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q599683(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome Brugada
Compêndio · Raras BR

Síndrome Brugada

ORPHA:130 · MONDO:0015263
Prevalência
1-5 / 10 000
Herança
Autosomal dominant, Not applicable
CID-10
I49.8 · Outras arritmias cardíacas especificadas
CID-11
Ensaios
13 ativos
Início
Adult, Childhood
Prevalência
20.0 (Europe)
MedGen
UMLS
C1142166
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades